[1]胡光辉,刘亚峰.唑来膦酸注射液对行髋关节置换术患者骨代谢的影响[J].新乡医学院学报,2023,40(10):960-964.[doi:10.7683/xxyxyxb.2023.10.010]
 HU Guanghui,LIU Yafeng.Effect of zoledronic acid injection on bone metabolism in patients undergoing hip replacement[J].Journal of Xinxiang Medical University,2023,40(10):960-964.[doi:10.7683/xxyxyxb.2023.10.010]
点击复制

唑来膦酸注射液对行髋关节置换术患者骨代谢的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年10
页码:
960-964
栏目:
临床研究
出版日期:
2023-10-05

文章信息/Info

Title:
Effect of zoledronic acid injection on bone metabolism in patients undergoing hip replacement
作者:
胡光辉1刘亚峰2
〔1.开封市中心医院骨科,河南 开封 475000;2.河南省洛阳正骨医院(河南省骨科医院)人工关节翻修科,河南 郑州 450000〕
Author(s):
HU Guanghui1LIU Yafeng2
〔1.Department of Orthopedics,Kaifeng Central Hospital,Kaifeng 475000,Henan Province,China;2.Department of Artificial Joint Revision,Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital),Zhengzhou 450000,Henan Province,China〕
关键词:
唑来膦酸髋关节置换术骨代谢骨密度
Keywords:
zoledronic acidhip replacementbone metabolismbone density
分类号:
R687.4
DOI:
10.7683/xxyxyxb.2023.10.010
文献标志码:
A
摘要:
目的 探讨唑来膦酸注射液对行髋关节置换术患者骨代谢的影响。
方法 选择2017年1月至2020年7月于开封市中心医院骨科行髋关节置换术的199例患者为研究对象,根据治疗方式将患者分为对照组(n=93)和观察组(n=106)。2组患者均行非骨水泥型全髋关节置换术,对照组患者于术后第2天口服碳酸钙D3咀嚼片,每次600 mg,每日睡前1次,连续用药2 a;观察组患者在对照组治疗基础上,分别于术后第7天及术后1、2 a各给予唑来膦酸注射液(100 mL)静脉滴注1次,滴注时间不少于15 min。于术前及术后2 a分别采集2组患者静脉血,采用酶联免疫吸附法检测血清骨代谢指标水平,包括骨吸收标志物I型胶原羧基端肽β特殊序列(β-CTX)、抗酒石酸酸性磷酸酶-5b(TRAP-5b)和骨形成标志物骨钙素(BGP)、骨特异性碱性磷酸酶(BALP)、Ⅰ型前胶原羧基末端肽(PICP)。分别于术前、术后1 a及术后2 a,采用双能 X 射线吸收测定法及Gruen分区法检测2组患者假体周围骨密度值。采用X线片测量2组患者术后2 a 股骨假体下沉距离。分别于术前及术后2 a,采用Harris髋关节评分评估2组患者的髋关节功能。
结果 术前,2组患者的血清β-CTX、TRAP-5b、BGP、BALP、PICP水平比较差异无统计学意义(P>0.05);术后2 a,观察组患者的血清β-CTX、TRAP-5b水平显著低于对照组(P<0.05),血清BGP、BALP、PICP水平显著高于对照组(P<0.05);2组患者术后2 a的血清β-CTX、TRAP-5b水平均显著低于术前(P<0.05),血清BGP、BALP、PICP水平均显著高于术前(P<0.05)。术前及术后1 a,2组患者的假体周围平均骨密度比较差异无统计学意义(P>0.05);术后2 a,观察组患者的假体周围平均骨密度显著高于对照组(P<0.05);2组患者术后1 a和术后2 a的假体周围平均骨密度均显著低于术前(P<0.05);对照组患者术后2 a的假体周围平均骨密度显著低于术后1 a(P<0.05);观察组患者术后1 a与术后2 a的假体周围平均骨密度比较差异无统计学意义(P>0.05)。术后2 a,对照组和观察组患者的股骨假体下沉距离分别为(0.74±0.20)、(0.57±0.21) mm;观察组患者的股骨假体下沉距离显著小于对照组(t=5.844,P<0.05)。术前,2组患者的Harris髋关节各维度评分及总评分比较差异无统计学意义(P>0.05);术后2 a,观察组患者的Harris髋关节各维度评分及总评分均显著高于对照组(P<0.05);2组患者术后 2 a 的Harris髋关节各维度评分及总评分均显著高于术前(P<0.05)。
结论 唑来膦酸注射液可有效改善髋关节置换术后患者的骨转换指标,抑制骨吸收和减少假体周围骨量,增加假体周围骨密度,延缓术后假体下沉,改善患者髋关节功能,值得临床推广。
Abstract:
Objective To investigate the influence of zoledronic acid injection on bone metabolism in patients undergoing hip replacement.
Methods A total of 199 patients who underwent hip replacement in the Department of Orthopedics,Kaifeng Central Hospital from January 2017 to July 2020 were selected as the research subjects.According to the treatment methods,the patients were divided into the control group (n=93) and the observation group (n=106).The patients in the two groups underwent cementless total hip replacement.The patients in the control group took calcium carbonate D3 chewable tablets on the second postoperative day orally,600 mg each time,once a day at bedtime for 2 years.On the basis of the treatment of the control group,the patients in the observation group were given intravenous infusion of 100 mL zoledronic acid injection on the 7th day and 1,2 years after surgery,respectively,the infusion time was not less than 15 min.Venous blood samples were collected before and 2 weeks after surgery,and the levels of serum bone metabolism indexes such as type Ⅰ collagen carboxy-terminal peptide β specific sequence (β-CTX),tartrate resistant acid phosphatase (TRAP-5b) ,and bone formation markes such as bone glaprotein (BGP),bone-specific alkaline phosphatase (BALP) and type I procollagen carboxy-terminal peptide (PICP) were detected by enzyme-linked immunosorbent assay.Before surgery,1 year and 2 years after surgery,the bone mineral density around the prosthesis of patients in the two groups was measured by dual-energy X-ray absorptiometry and Gruen partition method.The subsidence distance of the femoral prosthesis was measured by X-ray film at 2 years after surgery.Before surgery and 2 years after surgery,the hip function of patients in the two groups was evaluated by Harris hip score.
Results There was no significant differences in serum β-CTX,TRAP-5b,BGP,BALP and PICP levels between the two groups before surgery (P>0.05);at 2 years after surgery,the levels of serum β-CTX and TRAP-5b of patiens in the observation group were significantly lower than those in the control group (P< 0.05),and the levels of serum BGP,BALP and PICP were significantly higher than those in the control group (P<0.05);the levels of serum β-CTX and TRAP-5b of patients in the two groups at 2 years after surgery were significantly lower than those before surgery (P<0.05),and the levels of serum BGP,BALP and PICP were significantly higher than those before surgery (P<0.05).There was no significant difference in the average bone mineral density around the prosthesis of patients between the two groups before surgery and 1 year after surgery (P> 0.05);at 2 years after surgery,the average bone mineral density around the prosthesis of patients in the observation group was significantly higher than that in the control group (P<0.05);the average bone mineral density around the prosthesis of patients in the two groups at 1 and 2 years after surgery was significantly lower than that before surgery (P<0.05);the average bone mineral density around the prosthesis of patients in the control group at 2 years after surgery was significantly lower than that at 1 year after surgery (P<0.05);there was no significant difference in the average bone mineral density around the prosthesis of patients in the observation group between 1 year after surgery and 2 years after surgery (P>0.05).At 2 years after surgery,the subsidence distance of femoral prosthesis of patients in the control group and the observation group was (0.74±0.20) and (0.57±0.21) mm,respectively;the subsidence distance of femoral prosthesis of patients in the observation group was significantly smaller than that in the control group (P<0.05).Before operation,there was no significant difference in the Harris hip scores of each dimension and total score of patients between the two groups (P>0.05);at 2 years after surgery,the Harris hip scores of each dimension and total score of patients in the observation group were significantly higher than those in the control group(P<0.05);the Harris hip scores of each dimension and total score of patients in the two groups at 2 years after surgery were significantly higher than those before surgery(P<0.05).
Conclusion Zoledronic acid injection can effectively improve the bone turnover index of patients after hip replacement,inhibit the bone absorption and decrease the bone mass around the prosthesis,increase the bone density around the prosthesis,delay the sinking of the prosthesis,and improve the hip joint function of patients,which deserves to be promoted in clinical practices.

参考文献/References:

[1] KUTSAL F Y,ERGIN ERGANI G O.Vertebral compression fractures:still an unpredictable aspect of osteoporosis[J].Turk J Med Sci,2021,51(2):393-399.
[2] 柏小金,韩小松,向柄彦,等.后外侧微创入路行全髋关节置换术治疗老年股骨颈骨折的早期疗效[J].实用医学杂志,2022,38(12):1456-1460.
BAI X J,HAN X S,XIANG B Y,et al.Analysis of early efficacy of total hip arthroplasty through posterolateral minimally invasive approach for elderly femoral neck fractures[J].J Pract Med,2022,38(12):1456-1460.
[3] BLACK D M,REID I R,NAPOLI N,et al.The interaction of acute-phase reaction and efficacy for osteoporosis after zoledronic acid:HORIZON pivotal fracture trial[J].J Bone Miner Res,2022,37(1):21-28.
[4] ZHOU W,LIU Y,GUO X,et al.Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis[J].Osteoporos Int,2019,30(8):1581-1589.
[5] 《中国老年骨质疏松症诊疗指南》工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS IN THE ELDERLY IN CHINA WORKING GROUP,OSTEOPOROSIS BRANCH OF CHINESE GERONTOLOGY AND GERONTOLOGY SOCIETY,MA Y Z,et al.2018 China guideline for diagnosis and treatment of senile osteoporosis[J].Chin J Osteopor,2018,24(12):1541-1567.
[6] TEN BROEKE R H,HENDRICKX R P,LEFFERS P,et al.Randomised trial comparing bone remodelling around two uncemented stems using modified Gruen zones[J].Hip Int,2012,22(1):41-49.
[7] KUMAR P,SEN R,AGGARWAL S,et al.Reliability of modified Harris Hip score as a tool for outcome evaluation of total hip replacements in Indian population[J].J Clin Orthop Trauma,2019,10(1):128-130.
[8] ALSAMRI M T,AL-HAMMADI S,ISLAM B,et al.Zoledronic acid and bone cellular respiration[J].J Bone Miner Metab,2018,36(4):392-398.
[9] 黄晓林,廖健,洪伟,等.破骨细胞形成过程中唑来膦酸的作用途径及机制[J].中国组织工程研究,2019,23(17):2716-2721.
HUANG X L,LIAO J,HONG W,et al.Zoledronic acid in osteo-clastogenesis:roles and mechanisms[J].J Clin Rehabil Tis Eng Res,2019,23(17):2716-2721.
[10] CHENG Y T,LIAO J,ZHOU Q,et al.Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats[J].Exp Biol Med (Maywood),2021,246(15):1727-1739.
[11] CLZARDIN P,COLEMAN R,PUPPO M,et al.Bone metastasis:mechanisms,therapies,and biomarkers[J].Physiol Rev,2021,101(3):797-855.
[12] XIONG Y,HE T,WANG Y,et al.CKD stages,bone metabolism markers,and cortical porosity index:associations and mediation effects analysis[J].Front Endocrinol (Lausanne),2021,12:775066.
[13] DI MEDIO L,BRANDI M L.Advances in bone turnover markers[J].Adv Clin Chem,2021,105:101-140.
[14] 邱伟,连星烨.唑来膦酸干预老年骨质疏松性股骨转子间骨折髋关节置换后患者骨密度,骨代谢标志物的2年随访[J].中国组织工程研究,2021,25(33):5265-5272.
QIU W,LIAN X Y.Effect of zoledronic acid on bone mineral density and bone metabolism markers in elderly patients with osteoporotic intertrochanteric fracture after hip arthroplasty:2-year follow-up[J].J Clin Rehabil Tis Eng Res,2021,25(33):5265-5272.
[15] YUAN M,SHI X,SU Q,et al.A prospective randomized controlled trial on the short-term effectiveness of domestic robot-assisted total knee arthroplasty[J].Chin J Repair Reconstruc Surg,2021,35(10):1251-1258.
[16] 陈拥,孙阳.唑来膦酸对髋关节置换后股骨侧假体下沉的影响[J].中国组织工程研究,2022,26(12):1812-1815.
CHEN Y,SUN Y.Effect of zoledronic acid on femoral implant subsidence after hip arthroplasty[J].J Clin Rehabil Tis Eng Res,2022,26(12):1812-1815.
[17] 叶征,陈舰,缪佳庆.绝经期女性髋关节置换术后应用唑来膦酸对股骨假体周围骨密度及PICP、β-CTX、ALP、BALP水平的影响[J].临床和实验医学杂志,2021,20(19):2085-2089.
YE Z,CHEN J,MIAO J Q.Effect of zoledronic acid on periprosthetic bone mineral density and levels of PICP,β-CTX,ALP and BALP in postmenopausal women after hip replacement[J].J Clin Exp Med,2021,20(19):2085-2089.

相似文献/References:

[1]张新建,王晖玥,刘湘钰,等.右美托咪啶对行髋关节置换术老年高血压患者血压和心率的影响[J].新乡医学院学报,2020,37(1):048.[doi:10.7683/xxyxyxb.2020.01.012]
 ZHANG Xinjian,WANG Huiyue,LIU Xiangyu,et al.Effect of dexmedetomidine on blood pressure and heart rate in elderly patients with hypertension undergoing hip replacement[J].Journal of Xinxiang Medical University,2020,37(10):048.[doi:10.7683/xxyxyxb.2020.01.012]
[2]张 森,邹坤明,单海洋,等.关节腔内注射氨甲环酸联合术后引流管临时夹闭对人工全髋关节置换术效果的影响[J].新乡医学院学报,2017,34(5):374.[doi:10.7683/xxyxyxb.2017.05.007]
 ZHANG Sen,ZOU Kun-ming,SHAN Hai-yang,et al.Effect of intraarticular injection of tranexamic acid combined with postoperative temporary occlusion of the drainage tube on the effect of total hip replacement[J].Journal of Xinxiang Medical University,2017,34(10):374.[doi:10.7683/xxyxyxb.2017.05.007]

更新日期/Last Update: 2023-10-05